FDA Rejects Two Proposed Cancer Drugs Developed in China
The Food and Drug Administration rejected two proposed new cancer drugs that were developed in China, underscoring a tougher U.S. regulatory stance toward such drugs.Hong Kong-based
Hutchmed Ltd.
said Monday…